The role of sex genotype in paediatric CNS tumour incidence and survival
Open Access
- 5 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Child's Nervous System
- Vol. 37 (7), 2177-2186
- https://doi.org/10.1007/s00381-021-05165-0
Abstract
Purpose Evidence exists, in CNS germinomas and medulloblastomas (MB), that patient sex significantly influences incidence and outcome. The role of sex genotype in other paediatric CNS tumours remains unclear. This study sought to examine the role of sex genotype in CNS tumour incidence and overall survival (OS). Methods Age-adjusted incidence and OS rates were collected from the Surveillance Epidemiology and End Result (SEER) registry between 2000 and 2011 for common paediatric (<=19 years) CNS tumours: pilocytic astrocytoma (PA), anaplastic astrocytoma, glioblastoma (GBM), medulloblastoma, supratentorial CNS embryonal tumour, ependymoma, and germinoma. All patients with histologically confirmed, ICD-03 coded, first tumours, were included. Kaplan-Meier and Cox regression analyses were used to calculate hazard ratios (HR). Results The total cases are as follows: males=3018 and females=2276. Highest incidence was seen in PA (n=2103). GBM displayed the worst OS, whilst PA displayed the best. Higher incidence was observed in males for all tumours, except PA. Females with ependymoma had significantly better OS compared to males, whereas males with germinomas had better OS compared to females. Females <1 year with AA had better OS than males. Increasing age significantly improved male and female survival in ependymoma and medulloblastoma. Conclusion Interrogating population-based registries such as SEER minimises bias and provides credible data. Observed differences in incidence and OS between the sexes for different paediatric CNS tumours provide useful prognostic information for clinicians. Sex genotype was a significant independent prognostic factor in ependymomas and germinomas. Further investigation of possible epigenetic and hormonal differences may provide sex-specific vulnerabilities that may be exploitable for targeted therapy.This publication has 49 references indexed in Scilit:
- Pediatric glioblastoma multiforme: A single-institution experienceIndian Journal of Medical and Paediatric Oncology, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006Cancer, 2010
- The Epigenetics of Sex Differences in the Brain: Figure 1.Journal of Neuroscience, 2009
- Incidence Patterns of Central Nervous System Germ Cell TumorsJournal of Pediatric Hematology/Oncology, 2009
- Gender differences in facial expression recognition in survivors of pediatric brain tumorsPsycho‐Oncology, 2008
- Sex-specific genetic architecture of human diseaseNature Reviews Genetics, 2008
- Gender affects survival for medulloblastoma only in older children and adults: A study from the surveillance epidemiology and end results registryPediatric Blood & Cancer, 2008
- Epigenetic differences between male and female bovine blastocysts produced in vitroPhysiological Genomics, 2008
- Medulloblastoma in adultsInternational Journal of Radiation Oncology*Biology*Physics, 1995